|Articles|September 16, 2013

Intelligent Statistical Monitoring Results video

A conversation with Marc Buyse, founder of CluePoints on risk based monitoring in clinical trials

A conversation with Marc Buyse, founder of CluePoints on risk based monitoring in clinical trials

This video is part of a series of conversations on risk-based monitoring. Click here to see all the videos.

For more videos of Marc Buyse, see also:

Intelligent Statistical Monitoring Study Signals

What is Misunderstood about RBM

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Lab orchestration is often reduced to scheduling and automation, but a connected scientific record across the physical, logical, and digital domains is what actually makes AI-ready research possible. Credit: Stock.Adobe.com/VStudio.

Lab Orchestration Is Not What You Think It Is

ByRyan Bernhardt

September 11th 2026

Why Seizure Counts Alone Can't Define Success in Epilepsy Trials

ByAmélie Lothe,Andy Studna, Senior Editor

September 11th 2026

ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative

ByAndy Studna, Senior Editor

September 11th 2026

Recruitment in the Age of AI: Q&A with John Worden, Javara

ByJohn Worden,Andy Studna, Senior Editor

September 10th 2026

What It Actually Means to Embed the Patient Voice in Trial Design

ByAmélie Lothe,Andy Studna, Senior Editor

September 10th 2026

Trending on Applied Clinical Trials Online

What It Actually Means to Embed the Patient Voice in Trial Design

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

Recruitment in the Age of AI: Q&A with John Worden, Javara

ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization

From Participation to Understanding: Reframing Engagement in Clinical Trials